TipRanks
Go Ultimate55% OFF

Wellnex Life Ltd (WNX) AI Stock Analysis

GB:WNX

Wellnex Life Ltd

(LSE:WNX)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue reboundThe sustained revenue rebound over two fiscal years indicates improving scale and demand for Wellnex’s consumer healthcare products. Continued top-line expansion can strengthen channel relationships, support brand investment, and provide a broader base for future operating leverage if margins recover.
Negative Factors
Weak and declining gross marginThe sharp gross-margin contraction weakens the economics of Wellnex’s expanding revenue base and leaves less gross profit available to cover operating costs. Unless margins recover, higher sales may not translate into sustainable earnings, limiting the durability of the recent growth.

Wellnex Life Ltd (WNX) vs. iShares MSCI United Kingdom ETF (EWC)

-80%-60%-40%-20%0%20%40%GB:WNX-64.00%EWC+21.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
GBP 2.53M
Dividend Yield
―
Average Volume (3M)
62.81K
Price to Earnings (P/E)
-1.0
Beta (1Y)
0.00
Revenue Growth
6.04%
EPS Growth
87.27%
Country
UK
Employees
3
Sector
Consumer Defensive
Sector Strength
62
Industry
Packaged Foods

Wellnex Life Ltd Business Overview & Revenue Model

Company Description

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pai...

Wellnex Life Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

GB:WNX against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
AU:BUBAU:BUB48NeutralAUD 69.82M-15.00-11.08%―9.08%-183.87%
AU:NUCAU:NUC46NeutralAUD 12.55M-1.68-88.51%―11.96%-81.99%
AU:HCTAU:HCT29UnderperformAUD 12.14M-3.791795.70%―0.72%-486.96%
AU:NGSAU:NGS26UnderperformAUD 18.32M-0.01-130.72%―-33.05%94.22%

* Consumer Defensive Sector Average

Performance Comparison

-75%-50%-25%0%25%GB:WNXAU:BUBAU:NUCAU:HCTAU:NGSDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
GB:WNX and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:WNXWellnex Life Ltd4.50-8.00-64.00%
AU:BUBBubs Australia Ltd.0.08-0.07-48.00%
AU:NUCNuchev Pty Ltd0.08-0.06-42.86%
AU:HCTHolista Colltech Limited0.03-0.04-57.69%
AU:NGSNutritional Growth Solutions Ltd.0.02-0.00-9.52%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.